Darlene Webb
Investor Relations
Replay available
Anaergia Inc. (TSX: ANRG) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.

Investor Relations
Chief Executive Officer at Anaergia
Chief Financial Officer at Anaergia
Chief Operating Officer at Anaergia
at National Bank
at Roth Capital Partners
at Beacon Securities
at Alliance Global Partners
Ladies and gentlemen, thank you for joining us, and welcome to the Anaergia First Quarter twenty twenty six Conference Call and Webcast. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, I will now hand the conference over to Darlene Webb, Investor Relations. Please go ahead. Thank you very much, operator, and good morning, everyone. On today's call, we'll be discussing Anaergia's earnings for the first quarter of twenty twenty six, which ended 03/31/2026. If you're following along with our slide deck, which is available here or on our live streaming webcast, or you can also access it directly from the investors section of our website, my comments relate specifically to slides one through three. On slide two, you'll see that on today's call, am joined by Mr. Asaf An, Anaergia's Chief Executive Officer Mr. Greg Wolfe, Anaergia's Chief Financial Officer and Doctor. Yaniv Sherson, Anaergia's Chief Operating Officer. Before beginning our formal remarks, we would like to refer you to slide three of the presentation, which contains a caution on forward looking information and a note on the use of non GAAP measures. Listeners are reminded, as always, that today's discussion may contain forward looking statements that reflect current views with respect to future events. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated in these forward looking statements. Anaergia does not undertake to update any forward looking statements except as may be required by applicable laws. Listeners are urged to review the full discussion of risk factors in the company's prospectus that is filed with the Canadian securities regulators. You may now mov...